Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
JBIO
$20.91
+0.34%
JBIO
· Jade Biosciences, Inc.
$20.91
+0.07 (+0.34%)
At close · Aug 31
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.33B
Shares
63.60M
All earnings calls
Earnings call · FY2022 Q3
Jade Biosciences, Inc. (JBIO) Q3 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$19.60
Net income
-$13.59M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2022 · complete as-filed document